Abano Healthcare Group Limited provides oral healthcare services in New Zealand and Australia. More Details
Moderate growth potential and overvalued.
Share Price & News
How has Abano Healthcare Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ABA's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: ABA underperformed the NZ Healthcare industry which returned 10% over the past year.
Return vs Market: ABA underperformed the NZ Market which returned 3.1% over the past year.
Price Volatility Vs. Market
How volatile is Abano Healthcare Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
10 months ago | Simply Wall StImagine Owning Abano Healthcare Group (NZSE:ABA) And Wondering If The 45% Share Price Slide Is Justified
10 months ago | Simply Wall StWhat Does Abano Healthcare Group Limited's (NZSE:ABA) P/E Ratio Tell You?
11 months ago | Simply Wall StHere's Why Abano Healthcare Group (NZSE:ABA) Has A Meaningful Debt Burden
Is Abano Healthcare Group undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: ABA (NZ$3.78) is trading above our estimate of fair value (NZ$2.4)
Significantly Below Fair Value: ABA is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: ABA is unprofitable, so we can't compare its PE Ratio to the XO Healthcare industry average.
PE vs Market: ABA is unprofitable, so we can't compare its PE Ratio to the NZ market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ABA's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ABA is good value based on its PB Ratio (1x) compared to the NZ Healthcare industry average (1.5x).
How is Abano Healthcare Group forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ABA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: ABA is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ABA's is expected to become profitable in the next 3 years.
Revenue vs Market: ABA's revenue (4.4% per year) is forecast to grow slower than the NZ market (5.6% per year).
High Growth Revenue: ABA's revenue (4.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ABA's Return on Equity is forecast to be low in 3 years time (7.9%).
How has Abano Healthcare Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ABA is currently unprofitable.
Growing Profit Margin: ABA is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: ABA is unprofitable, and losses have increased over the past 5 years at a rate of 43.5% per year.
Accelerating Growth: Unable to compare ABA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ABA is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-13.5%).
Return on Equity
High ROE: ABA has a negative Return on Equity (-50.92%), as it is currently unprofitable.
How is Abano Healthcare Group's financial position?
Financial Position Analysis
Short Term Liabilities: ABA's short term assets (NZ$38.3M) do not cover its short term liabilities (NZ$53.0M).
Long Term Liabilities: ABA's short term assets (NZ$38.3M) do not cover its long term liabilities (NZ$252.5M).
Debt to Equity History and Analysis
Debt Level: ABA's debt to equity ratio (173.5%) is considered high.
Reducing Debt: ABA's debt to equity ratio has increased from 102.8% to 173.5% over the past 5 years.
Debt Coverage: ABA's debt is not well covered by operating cash flow (14.2%).
Interest Coverage: ABA is unprofitable, therefore interest payments are not well covered by earnings.
What is Abano Healthcare Group current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ABA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ABA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ABA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ABA's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: ABA is not paying a notable dividend for the NZ market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ABA's dividend in 3 years as they are not forecast to pay a notable one for the NZ market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Mr. Richard George Keys, BCom, CA has been Chief Executive Officer of Abano Healthcare Group Limited since November 2, 2015. Mr. Keys served as the Chief Financial Officer of Abano Healthcare Group Ltd. (f ...
CEO Compensation Analysis
Compensation vs Market: Richard's total compensation ($USD396.07K) is about average for companies of similar size in the NZ market ($USD397.47K).
Compensation vs Earnings: Richard's compensation has been consistent with company performance over the past year.
|Independent Deputy Chairman||no data||NZ$87.26k||0.065% |
|Independent Chairman of the Board||1.92yrs||NZ$139.43k||0.11% |
|Independent Director||0.33yr||NZ$2.69k||no data|
|Independent Director||4.08yrs||NZ$69.71k||0.039% |
|Independent Director||2.33yrs||NZ$80.41k||0.020% |
Experienced Board: ABA's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Abano Healthcare Group Limited's company bio, employee growth, exchange listings and data sources
- Name: Abano Healthcare Group Limited
- Ticker: ABA
- Exchange: NZSE
- Founded: 1961
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: NZ$99.347m
- Shares outstanding: 26.28m
- Website: https://www.abano.co.nz
Number of Employees
- Abano Healthcare Group Limited
- AMP Centre
- Level 11
- New Zealand
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ABA||NZSE (New Zealand Stock Exchange)||Yes||Ordinary Shares||NZ||NZD||Jan 1992|
Abano Healthcare Group Limited provides oral healthcare services in New Zealand and Australia. It operates through Dental New Zealand and Dental Australia segments. The company offers a range of general an ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/18 19:07|
|End of Day Share Price||2020/09/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.